Head And Neck Squamous Cell Carcinoma Hnscc Clinical Trials

ReadTheTrial indexes 1 studies for Head And Neck Squamous Cell Carcinoma Hnscc. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Head And Neck Squamous Cell Carcinoma Hnscc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Head And Neck Squamous Cell Carcinoma Hnscc

A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First Line Treatment for Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Expressing PD-L1 (CPS ≥20) (HexAgon-HN)

NCT06295731 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Head And Neck Squamous Cell Carcinoma Hnscc?

There are 1 clinical trials listed for Head And Neck Squamous Cell Carcinoma Hnscc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Head And Neck Squamous Cell Carcinoma Hnscc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Head And Neck Squamous Cell Carcinoma Hnscc trials in?

Current Head And Neck Squamous Cell Carcinoma Hnscc trials are distributed across: Phase 3 (1).

Find More Trials